1
|
As AK, Sahay RR, Radhakrishnan C, P S, Kandath S, Patil DY, Shete AM, M S, Ramakrishnan G, Moorkoth AP, Gupta N, Yadav PD, Godbole S, Ramakrishnan LV, Vadekkandiyil S, Ekkalayil D, V N, Balakrishnan A, Pullor NK, Asokan N, Joseph RK, Nair PR, Purayil SM, Mathew T, Kizhakkekandiyil R, Poovullathil JK, Ps KS, Pt U, George K, Rahim A, Kumar S, S S, Mohandas S, Rajan LS, Ramachandran SP, Thampi SP, Ashadevi, Anish TS, Chandran P, Mohan A, Vadakkayil B, Koroth SC, Hafeez N, Sasi RR, Abraham M. Clinico-epidemiological presentations and management of Nipah virus infection during the outbreak in Kozhikode district, Kerala state, India 2023. J Med Virol 2024; 96:e29559. [PMID: 38529536 DOI: 10.1002/jmv.29559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2023] [Revised: 02/09/2024] [Accepted: 03/13/2024] [Indexed: 03/27/2024]
Abstract
India experienced its sixth Nipah virus (NiV) outbreak in September 2023 in the Kozhikode district of Kerala state. The NiV is primarily transmitted by spillover events from infected bats followed by human-to-human transmission. The clinical specimens were screened using real-time RT-PCR, and positive specimens were further characterized using next-generation sequencing. We describe here an in-depth clinical presentation and management of NiV-confirmed cases and outbreak containment activities. The current outbreak reported a total of six cases with two deaths, with a case fatality ratio of 33.33%. The cases had a mixed presentation of acute respiratory distress syndrome and encephalitis syndrome. Fever was a persistent presentation in all the cases. The Nipah viral RNA was detected in clinical specimens until the post-onset day of illness (POD) 14, with viral load in the range of 1.7-3.3 × 104 viral RNA copies/mL. The genomic analysis showed that the sequences from the current outbreak clustered into the Indian clade similar to the 2018 and 2019 outbreaks. This study highlights the vigilance of the health system to detect and effectively manage the clustering of cases with clinical presentations similar to NiV, which led to early detection and containment activities.
Collapse
Affiliation(s)
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Shihabudheen P
- Iqraa International Hospital and Research Centre, Kozhikode, Kerala, India
| | | | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shamsudheen M
- Iqraa International Hospital and Research Centre, Kozhikode, Kerala, India
| | | | | | | | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Sheela Godbole
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | | | | | - Nithasha V
- Iqraa International Hospital and Research Centre, Kozhikode, Kerala, India
| | - Anukumar Balakrishnan
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India
| | | | | | - Reena Kalathil Joseph
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, Kerala, India
| | - Priyanka R Nair
- Iqraa International Hospital and Research Centre, Kozhikode, Kerala, India
| | | | - Thomas Mathew
- Director of Medical Education, Thiruvananthapuram, Kerala, India
| | - Rajaram Kizhakkekandiyil
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, Kerala, India
| | | | - Kannan Sabarinath Ps
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Ullas Pt
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Asma Rahim
- Government Medical College, Kozhikode, Kerala, India
| | - Surendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Siba S
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, Kerala, India
| | - Sreelekshmy Mohandas
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Lekshmi S Rajan
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shamin Punnath Ramachandran
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, Kerala, India
| | | | - Ashadevi
- Government Medical College, Kozhikode, Kerala, India
| | | | | | - Anuja Mohan
- Government Medical College, Kozhikode, Kerala, India
| | | | - Shaji Cheriya Koroth
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, Kerala, India
| | - Nimin Hafeez
- Government Medical College, Kozhikode, Kerala, India
| | | | - Minu Abraham
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, Kerala, India
| |
Collapse
|
2
|
Yadav PD, Sardana V, Deshpande GR, Shinde PV, Thangaraj JWV, George LS, Sapkal GN, Patil DY, Sahay RR, Shete AM, Joshi M, Murhekar M, Godbole S, Gupta N, Prakash S, Rathore M, Ujjainiya R, Singh AP, Mishra A, Dash D, Chaudhary K, Sengupta S. Neutralizing antibody responses to SARS-CoV-2 Omicron variants: Post six months following two-dose & three-dose vaccination of ChAdOx1 nCoV-19 or BBV152. Indian J Med Res 2024; 159:223-231. [PMID: 38517215 PMCID: PMC11050759 DOI: 10.4103/ijmr.ijmr_948_23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/18/2023] [Indexed: 03/23/2024] Open
Abstract
BACKGROUND OBJECTIVES The Omicron sub-lineages are known to have higher infectivity, immune escape and lower virulence. During December 2022 - January 2023 and March - April 2023, India witnessed increased SARS-CoV-2 infections, mostly due to newer Omicron sub-lineages. With this unprecedented rise in cases, we assessed the neutralization potential of individuals vaccinated with ChAdOx1 nCoV (Covishield) and BBV152 (Covaxin) against emerging Omicron sub-lineages. METHODS Neutralizing antibody responses were measured in the sera collected from individuals six months post-two doses (n=88) of Covishield (n=44) or Covaxin (n=44) and post-three doses (n=102) of Covishield (n=46) or Covaxin (n=56) booster dose against prototype B.1 strain, lineages of Omicron; XBB.1, BQ.1, BA.5.2 and BF.7. RESULTS The sera of individuals collected six months after the two-dose and the three-dose demonstrated neutralizing activity against all variants. The neutralizing antibody (NAbs) level was highest against the prototype B.1 strain, followed by BA5.2 (5-6 fold lower), BF.7 (11-12 fold lower), BQ.1 (12 fold lower) and XBB.1 (18-22 fold lower). INTERPRETATION CONCLUSIONS Persistence of NAb responses was comparable in individuals with two- and three-dose groups post six months of vaccination. Among the Omicron sub-variants, XBB.1 showed marked neutralization escape, thus pointing towards an eventual immune escape, which may cause more infections. Further, the correlation of study data with complete clinical profile of the participants along with observations for cell-mediated immunity may provide a clear picture for the sustained protection due to three-dose vaccination as well as hybrid immunity against the newer variants.
Collapse
Affiliation(s)
| | - Viren Sardana
- Big Data and Informatics Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | | | | | | | - Leyanna S. George
- Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | | | | | - Rima R. Sahay
- Maximum Containment Laboratory, Pune, Maharashtra, India
| | - Anita M. Shete
- Maximum Containment Laboratory, Pune, Maharashtra, India
| | - Madhavi Joshi
- Department of Science & Technology, Gujarat Biotechnology Research Centre, Gandhinagar, Gujarat, India
| | - Manoj Murhekar
- Department of Epidemiology & Biostatistics, ICMR-National Institute of Epidemiology, Chennai, Tamil Nadu, India
| | - Sheela Godbole
- ICMR-National Institute of Virology, Pune, Maharashtra, India
| | - Nivedita Gupta
- Division of Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | - Satyartha Prakash
- Big Data and Informatics Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Mamta Rathore
- Cardiometabolic Disease Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Rajat Ujjainiya
- Cardiometabolic Disease Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Ajay Pratap Singh
- Cardiometabolic Disease Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Aastha Mishra
- Cardiometabolic Disease Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Debasis Dash
- Cardiometabolic Disease Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Kumardeep Chaudhary
- Big Data and Informatics Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | - Shantanu Sengupta
- Big Data and Informatics Unit, CSIR-Institute of Genomics & Integrative Biology, New Delhi, India
- Academy of Scientific & Innovative Research, Ghaziabad, Uttar Pradesh, India
| | | |
Collapse
|
3
|
Munivenkatappa A, Yadav PD, Sahay RR, Sk K, Shete AM, Patil DY, Mohandas S, Jain R, Patil S, Sinha DP, Jayaswamy MM. Clinical, epidemiological, and molecular investigation of Kyasanur forest disease from Karnataka state, India during 2018-2019. Infect Dis (Lond) 2024; 56:145-156. [PMID: 37966909 DOI: 10.1080/23744235.2023.2282042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/30/2023] [Accepted: 11/07/2023] [Indexed: 11/17/2023] Open
Abstract
BACKGROUND In this study, we carried out an investigation of Kyasanur Forest Disease (KFD) suspected human cases reported in Karnataka state, India from December 2018 to June 2019. METHODS The clinical samples of KFD suspected cases (n = 1955) from 14 districts of Karnataka were tested for KFD using real-time RT-PCR and IgM ELISA. Further, the KFD-negative samples were tested for IgM antibodies against dengue and chikungunya viruses. Monkey samples (n = 276) and tick pools (n = 11582) were also screened using real-time RT-PCR. KFD-positive samples were further analysed using next-generation sequencing along with clinico-epidemiological analysis. RESULTS Of all, 173 (8.8%) cases tested positive for KFD either by real-time RT-PCR (n = 124), IgM ELISA (n = 53) or both tests (n = 4) from seven districts. Among KFD-negative cases, IgM antibody positivity was observed for dengue (2.6%), chikungunya (5.8%), dengue and chikungunya coinfection (3.7%). KFD cases peaked in January 2019 with fever, conjunctivitis, and myalgia as the predominant symptoms and a mortality of 4.6%. Among confirmed cases, 41% received a single dose and 20% received two doses of the KFD vaccine. Of the seven districts with KFDV positivity, Shivamogga and Hassan districts reported KFD viral RNA positivity in humans, monkeys, and ticks. Sequencing analysis of 2019 cases demonstrated a difference of less than 1.5% amino acid compared to prototype KFDV. CONCLUSION Although the KFD has been endemic in many districts of Karnataka state, our study confirms the presence of KFDV for the first time in two new districts, i.e. Hassan and Mysore. A comparative analysis of KFDV infection among the KFD-vaccinated and non-vaccinated populations demonstrated an insignificant difference.
Collapse
Affiliation(s)
- Ashok Munivenkatappa
- Indian Council of Medical Research-National Institute of Virology, Bangalore unit, Bangalore India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Kiran Sk
- District training centre, State institute of health and family welfare, Shivamogga, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Bangalore unit, Bangalore India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Bangalore unit, Bangalore India
| | - Diamond P Sinha
- ICMR-National Institute of Malaria Research, Field Unit, Raipur, India
| | - Manjunatha M Jayaswamy
- Indian Council of Medical Research-National Institute of Virology, Bangalore unit, Bangalore India
| |
Collapse
|
4
|
Punasanvala P, Sahay RR, Chandegara H, Patil DY, Shete AM, Balachandran C, Patel V, Bondre V, Rustam R, Patel K, Majumdar T, Shah K, Patil S, Sakhare K, Solanki J, Gawande P, Kumari V, Yadav PD. A rare case of Chandipura virus infection with haemorrhagic complications from Gujarat, India. J Med Virol 2023; 95:e29307. [PMID: 38087448 DOI: 10.1002/jmv.29307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2023] [Revised: 11/24/2023] [Accepted: 11/27/2023] [Indexed: 12/18/2023]
Affiliation(s)
- Pranav Punasanvala
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Hiren Chandegara
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Chandhu Balachandran
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Vipul Patel
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Vijay Bondre
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Rizwana Rustam
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Karma Patel
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Kavya Shah
- Gujarat Medical Education & Research Society General Hospital, Sabarkantha, Gujarat, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Kunal Sakhare
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Jayesh Solanki
- Directorate of Health Services, Gandhinagar, Gujarat, India
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Vaishnavi Kumari
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
5
|
Sahay RR, Patil DY, Shete AM, Nayak S, Parikh TM, Waghmare VT, Patel A, Shah A, Upadhyay K, Solanki J, Kanani A, Yadav PD. A fatal case of Crimean-Congo hemorrhagic fever from Kutch, Gujarat, India 2023. J Med Virol 2023; 95:e29218. [PMID: 37930137 DOI: 10.1002/jmv.29218] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Revised: 10/01/2023] [Accepted: 10/24/2023] [Indexed: 11/07/2023]
Affiliation(s)
- Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | | | | | - Amit Patel
- Zydus Hospitals, Ahmedabad, Gujarat, India
| | - Anand Shah
- Zydus Hospitals, Ahmedabad, Gujarat, India
| | - Kamlesh Upadhyay
- B.J. Medical College, New Civil Hospital, Asarwa, Ahmedabad, Gujarat, India
| | - Jayesh Solanki
- Directorate of Health Services, Gandhinagar, Gujarat, India
| | - Amit Kanani
- Office of the Deputy Director of A.H., FMD Typing Scheme, Ahmedabad, Gujarat, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
6
|
Shete AM, Patil DY, Jain R, Sahay RR, Chenayil S, Mohandas S, Yadav PD. Assessment of antibody kinetics in mpox cases with indigenously developed IgM and IgG ELISA. J Med Virol 2023; 95:e29073. [PMID: 37671729 DOI: 10.1002/jmv.29073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2023] [Revised: 08/24/2023] [Accepted: 08/24/2023] [Indexed: 09/07/2023]
Affiliation(s)
- Anita M Shete
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Rajlaxmi Jain
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Rima R Sahay
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shubin Chenayil
- State Surveillance Unit (IDSP), Directorate of Health Services (IDSP), Malappuram, Kerala, India
| | - Sreelekshmy Mohandas
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Pragya D Yadav
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
7
|
Yadav PD, Patil DY, Kumar S, Bergeron E, Rodriguez SE. Editorial: Emerging SARS-CoV-2 variants: genomic variations, transmission, pathogenesis, clinical impact, and interventions, volume II. Front Med (Lausanne) 2023; 10:1215309. [PMID: 37448801 PMCID: PMC10338110 DOI: 10.3389/fmed.2023.1215309] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Accepted: 05/19/2023] [Indexed: 07/15/2023] Open
Affiliation(s)
- Pragya D. Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y. Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College (AFMC), Pune, India
| | - Eric Bergeron
- Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States
| | - Sergio E. Rodriguez
- Galveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States
| |
Collapse
|
8
|
Sahay RR, Relhan V, Shete AM, Patil DY, Kumar LP, Kaur A, Majumdar T, Agarwal D, Gawande P, Lalmuanpuii G, Yemul J, Bahadur A, Vedpathak P, Guglani A, Mr PG, Mali D, Dighe H, Sarkale P, Kumar A, Jain R, Sahoo B, Kumar S, Yadav PD. Persistence of infectious monkey pox virus on the surfaces of isolation ward in a hospital setting, India. J Hosp Infect 2023:S0195-6701(23)00137-8. [PMID: 37120071 PMCID: PMC10133095 DOI: 10.1016/j.jhin.2023.03.026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2023] [Accepted: 03/01/2023] [Indexed: 05/01/2023]
Affiliation(s)
- Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Vineet Relhan
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Lekshmi P Kumar
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Aneet Kaur
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Deeksha Agarwal
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Gaby Lalmuanpuii
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Jyoti Yemul
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Amar Bahadur
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Pratiksha Vedpathak
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Aditi Guglani
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Pavani Gowda Mr
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Deepak Mali
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Hitesh Dighe
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Prasad Sarkale
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Abhinav Kumar
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Bijaylaxmi Sahoo
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Suresh Kumar
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India, Pin-110002
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021.
| |
Collapse
|
9
|
Yadav PD, Vasu M, Abubaker F, Sahay RR, Reghukumar A, Krishnan AB, Prabha K, Papu AK, Gopalakrishnan LG, Mundangalam N, Siddiq A, Patil DY, Shete AM, Abraham P, Prasad AR, Thavakara Koolothuvalappil A, Karunakaran K. An imported case of fatal encephalitis associated with mpox virus infection, India, July 2022. J Med Virol 2023; 95:e28755. [PMID: 37185835 DOI: 10.1002/jmv.28755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2022] [Revised: 11/30/2022] [Accepted: 04/12/2023] [Indexed: 05/17/2023]
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Meenakshy Vasu
- Public Health Department of Kerala, Directorate of Health Services (IDSP), Thiruvananthapuram, India
| | - Fazil Abubaker
- Daya General Hospital and Specialty Surgical Center, Thrissur, Kerala, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Anukumar Bala Krishnan
- Indian Council of Medical Research-National Institute of Virology, Alappuzha, Kerala, India
| | - Kavya Prabha
- Daya General Hospital and Specialty Surgical Center, Thrissur, Kerala, India
| | | | | | | | - Aboobaker Siddiq
- Daya General Hospital and Specialty Surgical Center, Thrissur, Kerala, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | | | - Kavya Karunakaran
- State Surveillance Unit (IDSP), Directorate of Health Services (IDSP), Thrissur, Kerala, India
| |
Collapse
|
10
|
Yadav PD, Kumar S, Agarwal K, Jain M, Patil DR, Maithal K, Mathapati B, Giri S, Mohandas S, Shete A, Sapkal G, Patil DY, Dey A, Chandra H, Deshpande G, Gupta N, Abraham P, Kaushal H, Sahay RR, Tripathy A, Nyayanit D, Jain R, Kumar A, Sarkale P, Baradkar S, Rajanathan C, Raju HP, Patel S, Shah N, Dwivedi P, Singh D. Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in rhesus macaques against SARS-CoV-2. J Med Virol 2023; 95:e28484. [PMID: 36625386 DOI: 10.1002/jmv.28484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2022] [Revised: 09/12/2022] [Accepted: 01/06/2023] [Indexed: 01/11/2023]
Abstract
The apprehension of needles related to injection site pain, risk of transmitting bloodborne pathogens, and effective mass immunization have led to the development of a needle-free injection system (NFIS). Here, we evaluated the efficacy of the NFIS and needle injection system (NIS) for the delivery and immunogenicity of DNA vaccine candidate ZyCoV-D in rhesus macaques against SARS-CoV-2 infection. Briefly, 20 rhesus macaques were divided into 5 groups (4 animals each), that is, I (1 mg dose by NIS), II (2 mg dose by NIS), III (1 mg dose by NFIS), IV (2 mg dose by NFIS) and V (phosphate-buffer saline [PBS]). The macaques were immunized with the vaccine candidates/PBS intradermally on Days 0, 28, and 56. Subsequently, the animals were challenged with live SARS-CoV-2 after 15 weeks of the first immunization. Blood, nasal swab, throat swab, and bronchoalveolar lavage fluid specimens were collected on 0, 1, 3, 5, and 7 days post infection from each animal to determine immune response and viral clearance. Among all the five groups, 2 mg dose by NFIS elicited significant titers of IgG and neutralizing antibody after immunization with enhancement in their titers postvirus challenge. Besides this, it also induced increased lymphocyte proliferation and cytokine response. The minimal viral load post-SARS-CoV-2 challenge and significant immune response in the immunized animals demonstrated the efficiency of NFIS in delivering 2 mg ZyCoV-D vaccine candidate.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital [Southern Command], Armed Forces Medical College [AFMC], Pune, India
| | - Kshitij Agarwal
- Department of Respiratory Medicine, University college of Medical Scieneces and Guru Teg Bahadur Hospital, University of Delhi, New Delhi, India
| | - Mukul Jain
- Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Dilip R Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Kapil Maithal
- Vaccine Technology Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Basavaraj Mathapati
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Suresh Giri
- Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Sreelekshmy Mohandas
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Gajanan Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Ayan Dey
- Vaccine Technology Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Harish Chandra
- Vaccine Technology Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Himanshu Kaushal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anuradha Tripathy
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Dimpal Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Abhimanyu Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Prasad Sarkale
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shreekant Baradkar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Hari Prasad Raju
- Vaccine Technology Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Satish Patel
- Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Niraj Shah
- Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Pankaj Dwivedi
- Zydus Research Centre, Cadila Healthcare Limited, Ahmedabad, Gujarat, India
| | - Dharmendra Singh
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
11
|
Patil DY, George S, Sahay RR, Chenayil S, Shete AM, Bhaskaramenon SC, Anish TS, Jain R, Nazeer FA, John R, Joshi Y, Sivaprasad R, Waghmare P, Ray S, Balakrishnan S, Kumari V, Sathe S, Yadav PD. A case of human buffalopox in Malappuram, India: The role of mpox surveillance in 2022. J Med Virol 2023; 95:e28580. [PMID: 36789762 DOI: 10.1002/jmv.28580] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Revised: 02/09/2023] [Accepted: 02/11/2023] [Indexed: 02/16/2023]
Affiliation(s)
- Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shubin Chenayil
- State Surveillance Unit (IDSP), Directorate of Health Services (IDSP), Malappuram, Kerala, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | | | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Reena John
- Government Medical College, Thrissur, Kerala, India
| | - Yash Joshi
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - R Sivaprasad
- Government Medical College, Manjeri, Kerala, India
| | - Priyanka Waghmare
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shilpa Ray
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | | | - Vaishnavi Kumari
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Shubhangi Sathe
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
12
|
Sahay RR, Patil DY, Sapkal GN, Shete AM, Yadav PD. Cases of SARS-CoV-2 reinfection with Omicron BA.2 post breakthrough infection with Delta and Kappa variants. Infect Dis (Lond) 2023; 55:63-66. [PMID: 35999819 DOI: 10.1080/23744235.2022.2114538] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Affiliation(s)
- Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
13
|
Kumar A, Rajan LS, Sabarinath PS K, Shete AM, Sahay RR, Patil DY, Ingole N, K K, Padinakarai AC, GB S, Shastri J, Padukone S, Joshi Y, Patil S, Majumdar T, Verma A, Yemul J, Shende N, Kumari V, Vedpathak P, Sathe S, Gawande P, Yadav PD. First detection of Varicella Zoster Virus clade 9 cases in India during mpox surveillance. Ann Med 2023; 55:2253733. [PMID: 37672487 PMCID: PMC10484040 DOI: 10.1080/07853890.2023.2253733] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/27/2023] [Revised: 08/01/2023] [Accepted: 08/27/2023] [Indexed: 09/08/2023] Open
Abstract
BACKGROUND The multi-country mpox outbreak across the globe has led to the systematic surveillance of mpox cases in India. During the surveillance of mpox, we encountered cases of Varicella Zoster Virus (VZV) in suspected mpox cases amongst children & adults. This study focused on the genomic characterization of VZV in India. METHODS A total of 331 mpox suspected cases were tested for VZV through real-time PCR, and the positive samples were subjected to next-generation sequencing to retrieve the whole genome of VZV using CLC genomics software. Phylogenetic analysis has been done in MEGA 11.0 software to identify circulating clades. RESULT Of the 331 suspected cases, 28 cases with vesicular rashes were found to be positive for VZV. The maximum genome could be retrieved from the clinical specimens of 16 cases with coverage greater than 98% when mapped with reference strain Dumas (NC 001348). The phylogenetic analyses of these sequences determined the circulation of clades 1, 5, and 9 in India. Further, the sequence analysis demonstrated non-synonymous single nucleotide polymorphism (SNPs) among specific ORF of VZV including ORF 14, ORF 22, ORF 36, ORF 37 and ORF 51. Although clade 1 and 5 has been reported earlier, the circulation of clade 9 of VZV has been determined for the first time in India. CONCLUSION Although the circulation of different clades of VZV was reported from India, the presence of clade 9 was detected for the first time during the mpox surveillance.
Collapse
Affiliation(s)
- Abhinendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Lekshmi S. Rajan
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Anita M. Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rima R. Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y. Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nayana Ingole
- Virus Research and Diagnostic Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, India
| | - Kaveri K
- King Institute of Preventive Medicine and Research, Chennai, India
| | | | - Shantala GB
- Bangalore Medical College and Research Institute, Bengaluru, India
| | - Jayanthi Shastri
- Virus Research and Diagnostic Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, India
| | | | - Yash Joshi
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Ajay Verma
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jyoti Yemul
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nandini Shende
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Vaishnavi Kumari
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pratiksha Vedpathak
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Shubhangi Sathe
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pragya D. Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| |
Collapse
|
14
|
Shete AM, Yadav PD, Kumar A, Patil S, Patil DY, Joshi Y, Majumdar T, Relhan V, Sahay RR, Vasu M, Gawande P, Verma A, Kumar A, Dhakad S, Krishnan AB, Chenayil S, Kumar S, Abraham P. Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage. J Infect 2023; 86:66-117. [PMID: 36179885 PMCID: PMC9534117 DOI: 10.1016/j.jinf.2022.09.024] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Accepted: 09/22/2022] [Indexed: 02/04/2023]
Affiliation(s)
- Anita M. Shete
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Pragya D. Yadav
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India,Corresponding author
| | - Abhinendra Kumar
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Savita Patil
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Deepak Y. Patil
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Yash Joshi
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Triparna Majumdar
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Vineet Relhan
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi 110002, India
| | - Rima R. Sahay
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Meenakshy Vasu
- Public Health Department of Kerala, Directorate of Health Services, Thiruvananthapuram 695035, India
| | - Pranita Gawande
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Ajay Verma
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| | - Arbind Kumar
- All India Institute of Medical Sciences, New Delhi 110029, India
| | - Shivram Dhakad
- All India Institute of Medical Sciences, New Delhi 110029, India
| | - Anukumar Bala Krishnan
- Indian Council of Medical Research-National Institute of Virology, Alappuzha, Kerala 688005, India
| | - Shubin Chenayil
- State Surveillance Unit (IDSP), Directorate of Health Services (IDSP), Malappuram, Kerala 688005, India
| | - Suresh Kumar
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi 110002, India
| | - Priya Abraham
- Maximum Containment Facility, National Institute of Virology, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra 411021, India
| |
Collapse
|
15
|
Relhan V, Sahay RR, Shete AM, Yadav PD, Sahoo B, Patil DY, Kumar S, Premachandran Syamaladevi KS, Dar L, Mohandas S, Abraham P. Clinical presentation, viral kinetics, and management of human monkeypox cases from New Delhi, India 2022. J Med Virol 2023; 95:e28249. [PMID: 36271515 DOI: 10.1002/jmv.28249] [Citation(s) in RCA: 6] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2022] [Revised: 10/17/2022] [Accepted: 10/18/2022] [Indexed: 01/11/2023]
Abstract
We describe the clinical and demographic characteristics, virological follow-up, and management of five confirmed monkeypox cases from New Delhi, India without any international travel history. The viral load kinetics and viral clearance were estimated in oropharyngeal swabs (OPS), nasopharyngeal swabs (NPS), EDTA blood, serum, urine, and various lesion specimens on every fourth day of follow-up ranging from 5 to 24 post onset day (POD) of illness. All five cases presented with mild to moderate-grade intermittent fever, myalgia, and lesions on the genitals, groins, lower limb, trunk, and upper limb. Four cases had non-tender firm lymphadenopathy. No secondary complications or sexually transmitted infections were recorded in these cases except for the presence of viral hepatitis B infection marker hepatitis B virus surface antigen (HBsAg) in one case. All the cases were mild and had a good recovery. A higher viral load was detected in lesion fluid (POD 9), followed by lesion roof (POD 9), urine (POD 5), lesion base (POD 5), and OPS/NPS (POD 5). The monkeypox virus (MPXV) DNA was detected in clinical samples from 5th to 24th POD. These monkeypox cases without international travel history suggest the underdiagnosed monkeypox infection in the community. This emphasizes the need for active surveillance of MPXV in the high-risk population such as men having sex with men and female sex workers.
Collapse
Affiliation(s)
- Vineet Relhan
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Bijaylaxmi Sahoo
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Suresh Kumar
- Maulana Azad Medical College and Lok Nayak Hospital, New Delhi, India
| | | | - Lalit Dar
- All India Institute of Medical Sciences, New Delhi, India
| | - Sreelekshmy Mohandas
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
16
|
Sahay RR, Yadav PD, Nandapurkar A, Dhawde R, Suryawanshi A, Patil DY, Shete AM, Sapkal GN, Kulkarni M, Gurav YK, Deshpande GR, Ghodke JS, Jain R, Hawale R, Kalele K, Yemul J, Gawande P, Abraham P. Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months. Hum Vaccin Immunother 2022; 18:2156753. [PMID: 36576223 PMCID: PMC9891675 DOI: 10.1080/21645515.2022.2156753] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
We have evaluated the immunogenicity of two dose of Covaxin given at a one-month interval to two adult populations, i.e. COVID-19 naïve-vaccinated individuals (n = 118) and COVID-19 recovered individuals (n = 128) with the vaccination. The immune response in the study population were assessed at three follow-ups, namely at one month post first dose, one and six months after the second dose. The persistence of S1RBD IgG and neutralizing antibodies for six months post vaccination was observed at different time intervals. The enhanced immune response was observed in both the participant groups. The study emphasizes the need for a booster dose post six months of vaccination.
Collapse
Affiliation(s)
- Rima R. Sahay
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pragya D. Yadav
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India,CONTACT Pragya D. Yadav Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra411021, India
| | | | - Rutuja Dhawde
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Annasaheb Suryawanshi
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y. Patil
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anita M. Shete
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan N. Sapkal
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Yogesh K. Gurav
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gururaj R. Deshpande
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Rajlaxmi Jain
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Raj Hawale
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Kaumudi Kalele
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jyoti Yemul
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pranita Gawande
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Priya Abraham
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, India
| |
Collapse
|
17
|
Shastri J, Yadav PD, Agrawal S, Shete AM, Nyayanit DA, Parikh S, Gomare M, Sahay RR, Patil DY, Dudhmal M, Kadam N. Community transmission of SARS-CoV-2 with B.1.1.7 lineage in Mumbai, India. J Microbiol Immunol Infect 2022; 55:1116-1121. [PMID: 34772636 PMCID: PMC8563497 DOI: 10.1016/j.jmii.2021.10.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/21/2021] [Revised: 09/27/2021] [Accepted: 10/20/2021] [Indexed: 12/27/2022]
Abstract
The B.1.1.7 (Alpha) variant has been detected in Mumbai, India during February 2021. Subsequently, we retrieved 43 sequences from specimens of 51 COVID-19 cases from Mumbai. The sequence analysis revealed that the cases were mainly affected with Alpha variant which suggests its role in community transmission of SARS-CoV-2 in Mumbai, India.
Collapse
Affiliation(s)
- Jayanthi Shastri
- Molecular Diagnostic Reference Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, 400034, India,Corresponding author. Department of Microbiology T.N. Medical College & B. y. L. Nair Hospital i/c Molecular Diagnostic reference Laboratory Kasturba hospital for infectious diseases Mumbai, 400011, India. Fax: +91 22 23072663
| | - Pragya D. Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Sachee Agrawal
- Molecular Diagnostic Reference Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, 400034, India
| | - Anita M. Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Dimpal A. Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Swapneil Parikh
- Molecular Diagnostic Reference Laboratory, Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, 400034, India
| | - Mangala Gomare
- Public Health Department, Municipal Corporation of Greater Mumbai, Mumbai, Maharashtra, 400 001, India
| | - Rima R. Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Deepak Y. Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Manisha Dudhmal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Neelam Kadam
- Public Health Department, Municipal Corporation of Greater Mumbai, Mumbai, Maharashtra, 400 001, India
| |
Collapse
|
18
|
Shete AM, Patil DY, Sahay RR, Sapkal GN, Deshpande GR, Yadav PD. Waning natural and vaccine-induced immunity leading to reinfection with SARS-CoV-2 Omicron variant. Hum Vaccin Immunother 2022; 18:2127289. [PMID: 36170667 DOI: 10.1080/21645515.2022.2127289] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
We have investigated six COVID-19 recovered cases with two doses of Covishield vaccination followed by reinfection. The primary SARS-CoV-2 infection found to occur with B.1 and reinfection with Omicron BA.1 and BA.2 variants. The genomic characterization and duration between two infections confirms these cases as SARS-CoV-2 reinfection. The immune response determined at different time intervals demonstrated boost post two dose vaccination, decline in pre-reinfection sera post 7 months and rise post reinfection. In conclusion, it was observed that these cases got SARS-CoV-2 reinfection with declined hybrid immunity acquired from primary infection and two dose covishield vaccination. This findings suggests the need to protect the community through booster dose of vaccination and prevent further infections following personal hygiene and non-pharmaceutical interventions.
Collapse
Affiliation(s)
- Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gururaj R Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| |
Collapse
|
19
|
Sapkal G, Kant R, Dwivedi G, Sahay RR, Yadav PD, Deshpande GR, Singh R, Nyayanit DA, Patil DY, Shete-Aich AM, Zaman K, Chaudhari AK, Gupta N, Panda S, Abraham P, Bhargava B. Immune responses against different variants of SARS-CoV-2 including Omicron following 6 months of administration of heterologous prime-boost COVID-19 vaccine. J Travel Med 2022; 29:6542352. [PMID: 35244698 PMCID: PMC8903478 DOI: 10.1093/jtm/taac033] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/14/2022] [Revised: 02/17/2022] [Accepted: 01/18/2022] [Indexed: 12/03/2022]
Abstract
Comparative analysis at one- and six-months post-vaccination showed modest reduction in S1-RBD IgG antibody and NAb titers against B.1, Alpha, Beta and Delta variants in heterologous and homologous vaccine recipients groups. However, significant reduction in NAb titers against Omicron in vaccinees’ sera post-six months underlines need for cautious prospective follow-up.
Collapse
Affiliation(s)
- Gajanan Sapkal
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Rajni Kant
- Indian Council of Medical Research-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, 273013, India
| | - Gaurav Dwivedi
- Indian Council of Medical Research-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, 273013, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Gururaj R Deshpande
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Rajeev Singh
- Indian Council of Medical Research-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, 273013, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Anita M Shete-Aich
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Kamran Zaman
- Indian Council of Medical Research-Regional Medical Research Centre (RMRC), Gorakhpur, Uttar Pradesh, 273013, India
| | - Anil K Chaudhari
- Chief Medical Officer, Community Health Centre, Siddarthnagar, Uttar Pradesh, 272207, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology (ICMR-NIV), Pune, Maharashtra, 411021, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| |
Collapse
|
20
|
Yadav PD, Mohandas S, Shete AM, Nyayanit DA, Gupta N, Patil DY, Sapkal GN, Potdar V, Kadam M, Kumar A, Kumar S, Suryavanshi D, Mote CS, Abraham P, Panda S, Bhargava B. SARS-CoV-2 Kappa Variant Shows Pathogenicity in a Syrian Hamster Model. Vector Borne Zoonotic Dis 2022; 22:289-296. [PMID: 35580212 DOI: 10.1089/vbz.2021.0080] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Objectives: The emergence of SARS-CoV-2 lineage B.1.617 variants in India has been associated with a surge in the number of daily infections. We investigated the pathogenic potential of Kappa (B.1.617.1) variant in Syrian golden hamsters. Methods: Two groups of Syrian golden hamsters (18 each) were inoculated intranasally with SARS-CoV-2 isolates, B.1 (D614G) and Kappa variant, respectively. The animals were monitored daily for the clinical signs and body weight. Throat swab, nasal wash, and organ samples (lungs, nasal turbinate, trachea) were collected and screened using SARS-CoV-2-specific RT-qPCR. Histopathologic evaluation of the lung samples was performed. Results: The hamsters infected with the Kappa variant demonstrated increased body weight loss compared to the B.1 lineage isolate. The highest viral RNA load was observed in the nasal turbinate and lung specimens of animals infected with both variants. A significantly higher sgRNA load was observed in the nasal swabs (7 DPI), trachea (3 DPI), and lungs (3 DPI) of hamsters infected with the Kappa variant. Neutralizing antibody response generated in the B.1 lineage-infected hamster sera were comparable against both B.1 and Kappa variant in contrast to Kappa variant-infected hamsters, which showed lower titers against B.1 lineage isolate. Gross and microscopic evaluation of the lung specimens showed severe lung lesions in hamsters infected with Kappa variant compared to B.1. Conclusions: The study demonstrates pathogenicity of Kappa variant in hamsters evident with reduced body weight, high viral RNA load in lungs, and pronounced lung lesions. Both Kappa variant- and B.1-infected hamsters produced neutralizing antibodies against both variants studied.
Collapse
Affiliation(s)
- Pragya D Yadav
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Sreelekshmy Mohandas
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Anita M Shete
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Dimpal A Nyayanit
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Deepak Y Patil
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Varsha Potdar
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Manoj Kadam
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Abhimanyu Kumar
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College (AFMC), Pune, India
| | - Deepak Suryavanshi
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Chandrashekhar S Mote
- Department of Veterinary Pathology, Krantisinh Nana Patil College of Veterinary Science, Shirwal, India
| | - Priya Abraham
- Maximum Containment Facility, Indian Council of Medical Research, National Institute of Virology, Pune, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| |
Collapse
|
21
|
Pandit P, Bhatt P, Sahay RR, Joshi Y, Patil DY, Yadav PD. A case of breakthrough infection with SARS-CoV-2 Delta derivative and reinfection with Omicron variant in a fully vaccinated health care professional. J Infect 2022; 85:e15-e17. [PMID: 35447232 PMCID: PMC9014656 DOI: 10.1016/j.jinf.2022.04.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2022] [Accepted: 04/10/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Priyanka Pandit
- Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021
| | - Puneet Bhatt
- Army Hospital Research and Referral, New Delhi, India Pin-110010
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021
| | - Yash Joshi
- Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India Pin-411021.
| |
Collapse
|
22
|
Yadav PD, Sahay RR, Agrawal S, Shete A, Adsul B, Tripathy S, Nyayanit DA, Manrai M, Patil DY, Kumar S, Marwah V, Sapkal GN, Shastri J, Viswanathan R, Pandit P, Mishra Y, Chavan S, Joshi Y, Kumar TA, Majumdar T, Kumar A, Patil S, Munshi R, Desai U, Kaushal H, Suryawanshi A, Dudhmal M, Gawande P, Jain R, Waghmare A, Kalele K, Vedpathak P, Yemul J, Bodke P, Kore T, Kakrani AL, Athavale P, Suryawanshi P, Patsute S, Padbidri V, Awate P, Abraham P. Clinical, immunological and genomic analysis of the post vaccinated SARS-CoV-2 infected cases with Delta derivatives from Maharashtra, India, 2021. J Infect 2022; 85:e26-e29. [PMID: 35398410 PMCID: PMC8990527 DOI: 10.1016/j.jinf.2022.04.014] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Accepted: 04/02/2022] [Indexed: 11/29/2022]
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India.
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Sachee Agrawal
- Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, India
| | - Anita Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Srikanth Tripathy
- Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Manish Manrai
- Armed Forces Medical College, Pune, Maharashtra, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Sanjay Kumar
- Command Hospital (South Command), Pune, Maharashtra, India
| | - Vikas Marwah
- Army Institute of Cardio Thoracic Sciences, Pune, Maharashtra, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jayanthi Shastri
- Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, India
| | | | | | | | - Smita Chavan
- Seven Hills Hospital, Mumbai, Maharashtra, India
| | - Yash Joshi
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - T Ajai Kumar
- Army Institute of Cardio Thoracic Sciences, Pune, Maharashtra, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Abhinendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Renuka Munshi
- Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, India
| | - Unnati Desai
- Kasturba Hospital for Infectious Diseases, Mumbai, Maharashtra, India
| | - Himanshu Kaushal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Manisha Dudhmal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Ashwini Waghmare
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Kaumudi Kalele
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pratiksha Vedpathak
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jyoti Yemul
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Poonam Bodke
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Tejashri Kore
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - A L Kakrani
- Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India
| | - Prachi Athavale
- Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India
| | - Poonam Suryawanshi
- Dr. D.Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India
| | - Sudhir Patsute
- Naidu Infectious Diseases Hospital, Pune, Maharashtra, India
| | - Vikram Padbidri
- Department of Microbiology and Infection Control, Jehangir Hospital, Pune, Maharashtra, India
| | - Pradip Awate
- State Surveillance Officer, Integrated Disease Surveillance program, Pune, Maharashtra, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| |
Collapse
|
23
|
Yadav PD, Sapkal GN, Sahay RR, Patil DY, Agrawal S, Adsul B, Tripathy S, Deshpande GR, Nyayanit DA, Shete AM, Shastri J, Abraham P. Reduced neutralizing antibody response in naïve Covishield vaccinees against Omicron emphasizes booster vaccination. J Infect 2022; 85:90-122. [PMID: 35461911 PMCID: PMC9021040 DOI: 10.1016/j.jinf.2022.04.031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2022] [Accepted: 04/17/2022] [Indexed: 11/08/2022]
|
24
|
Yadav PD, Sapkal GN, Sahay RR, Patil DY, Deshpande GR, Jain R, Nyayanit DA, Shete AM, Suryawanshi A, Nandapurkar A, Gurav YK, Abraham P. Elevated neutralization of Omicron with sera of COVID-19 recovered and breakthrough cases vaccinated with Covaxin than two dose naïve vaccinees. J Infect 2022; 84:834-872. [PMID: 35318093 PMCID: PMC8934181 DOI: 10.1016/j.jinf.2022.03.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2022] [Accepted: 03/16/2022] [Indexed: 11/25/2022]
|
25
|
Gokhale M, Sudeep AB, Mathapati B, Balasubramanian R, Ullas PT, Mohandas S, Patil DR, Shete AM, Gopale S, Sawant P, Jain R, Holeppanavar M, Suryawanshi AT, Chopade G, Dhaigude S, Patil DY, Mourya DT, Yadav PD. Serosurvey for Nipah virus in bat population of southern part of India. Comp Immunol Microbiol Infect Dis 2022; 85:101800. [DOI: 10.1016/j.cimid.2022.101800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/28/2021] [Revised: 03/22/2022] [Accepted: 03/23/2022] [Indexed: 11/26/2022]
|
26
|
Yadav PD, Nyayanit DA, Gupta N, Shastri J, Sahay RR, Patil DY, Shete AM, Razdan A, Agrawal S, Kumar A, Majumdar T, Patil S, Sarkale P, Baradkar S, Dudhmal M, Kaur H, Aggarwal N. Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India. J Med Virol 2022; 94:3404-3409. [PMID: 35211985 PMCID: PMC9088542 DOI: 10.1002/jmv.27676] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Revised: 02/11/2022] [Accepted: 02/22/2022] [Indexed: 11/25/2022]
Abstract
International travel has been the major source for the rapid spread of new SARS‐CoV‐2 variants across the globe. During SARS‐CoV‐2 genomic surveillance, a total of 212 SARS‐CoV‐2 positive clinical specimens were sequenced using next‐generation sequencing. A complete SARS‐CoV‐2 genome could be retrieved from 90 clinical specimens. Of them, 14 sequences belonged to the Eta variant from clinical specimens of international travelers (n = 12) and local residents (n = 2) of India, and 76 belonged to other SARS‐CoV‐2 variants. Of all the Eta‐positive specimens, the virus isolates were obtained from the clinical specimens of six international travelers. Many variants of interest have been found to cause substantial community transmission or cluster infections. The detection of this variant with lethal E484K mutation across the globe and India necessitates persistent genomic surveillance of the SARS‐CoV‐2 variants, which would aid in taking preventive action.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India, 110029
| | - Jayanthi Shastri
- Molecular Diagnostic reference Laboratory, Kasturba hospital for infectious diseases, Mumbai, India, 400034
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Alpana Razdan
- Genestrings Diagnostic Centre Pvt. Ltd., 3, MMTC, Geetanjali Enclave, New Delhi, 110017
| | - Sachee Agrawal
- Molecular Diagnostic reference Laboratory, Kasturba hospital for infectious diseases, Mumbai, India, 400034
| | - Abhinendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Prasad Sarkale
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Shreekant Baradkar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Manisha Dudhmal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, 411021
| | - Harmanmeet Kaur
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India, 110029
| | - Neeraj Aggarwal
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India, 110029
| |
Collapse
|
27
|
Yadav PD, Sahay RR, Balakrishnan A, Mohandas S, Radhakrishnan C, Gokhale MD, Balasubramanian R, Abraham P, Gupta N, Sugunan AP, Khobragade R, George K, Shete A, Patil S, Thankappan UP, Dighe H, Koshy J, Vijay V, Gayathri R, Kumar PJ, Rahim A, Naveen A, Nair S, Rajendran VR, Jayasree V, Majumdar T, Jain R, Viswanathan P, Patil DY, Kumar A, Nyayanit DA, Sarkale P, Waghmare A, Baradkar S, Gawande P, Bodke P, Kalele K, Yemul J, Dhaigude S, Holepannawar M, Gopale S, Chopade G, Ray S, Waghmare P, Narayan J, Mathapati B, Kadam M, Kumar A, Suryawanshi A, Jose BP, Sivadas S, Akash NP, Vimisha TV, Keerthi KV. Nipah Virus Outbreak in Kerala State, India Amidst of COVID-19 Pandemic. Front Public Health 2022; 10:818545. [PMID: 35252095 PMCID: PMC8891450 DOI: 10.3389/fpubh.2022.818545] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2021] [Accepted: 01/03/2022] [Indexed: 12/29/2022] Open
Abstract
We report here a Nipah virus (NiV) outbreak in Kozhikode district of Kerala state, India, which had caused fatal encephalitis in a 12-year-old boy and the outbreak response, which led to the successful containment of the disease and the related investigations. Quantitative real-time reverse transcription (RT)-PCR, ELISA-based antibody detection, and whole genome sequencing (WGS) were performed to confirm the NiV infection. Contacts of the index case were traced and isolated based on risk categorization. Bats from the areas near the epicenter of the outbreak were sampled for throat swabs, rectal swabs, and blood samples for NiV screening by real-time RT-PCR and anti-NiV bat immunoglobulin G (IgG) ELISA. A plaque reduction neutralization test was performed for the detection of neutralizing antibodies. Nipah viral RNA could be detected from blood, bronchial wash, endotracheal (ET) secretion, and cerebrospinal fluid (CSF) and anti-NiV immunoglobulin M (IgM) antibodies from the serum sample of the index case. Rapid establishment of an onsite NiV diagnostic facility and contact tracing helped in quick containment of the outbreak. NiV sequences retrieved from the clinical specimen of the index case formed a sub-cluster with the earlier reported Nipah I genotype sequences from India with more than 95% similarity. Anti-NiV IgG positivity could be detected in 21% of Pteropus medius (P. medius) and 37.73% of Rousettus leschenaultia (R. leschenaultia). Neutralizing antibodies against NiV could be detected in P. medius. Stringent surveillance and awareness campaigns need to be implemented in the area to reduce human-bat interactions and minimize spillover events, which can lead to sporadic outbreaks of NiV.
Collapse
Affiliation(s)
- Pragya D. Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
- *Correspondence: Pragya D. Yadav
| | - Rima R. Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anukumar Balakrishnan
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, India
| | | | | | - Mangesh D. Gokhale
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - R. Balasubramanian
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Epidemiology and Communicable Diseases Division, Indian Council of Medical Research, New Delhi, India
| | - A. P. Sugunan
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, India
| | - Rajan Khobragade
- Health and Family Welfare Department, Government of Kerala, Thiruvananthapuram, India
| | - Kalpana George
- Department of Microbiology, Government Medical College, Kozhikode, India
| | - Anita Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Hitesh Dighe
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jijo Koshy
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, India
| | - Vivek Vijay
- Indian Council of Medical Research-National Institute of Virology, Kerala Unit, Alappuzha, India
| | - R. Gayathri
- Department of Medicine, Government Medical College, Kozhikode, India
| | - P. Jayesh Kumar
- Department of Medicine, Government Medical College, Kozhikode, India
| | - Asma Rahim
- Department of Community Medicine, Government Medical College, Kozhikode, India
| | - A. Naveen
- National Health Mission, Kozhikode, India
| | | | | | - V. Jayasree
- District Medical Office of Health, Health Department, Kozhikode, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Deepak Y. Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Abhinendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Dimpal A. Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Prasad Sarkale
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Ashwini Waghmare
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Shrikant Baradkar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Poonam Bodke
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Kaumudi Kalele
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jyoti Yemul
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Sachin Dhaigude
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | - Sanjay Gopale
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Ganesh Chopade
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Shilpa Ray
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Priyanka Waghmare
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Jitendra Narayan
- Epidemiology and Communicable Diseases Division, Indian Council of Medical Research, New Delhi, India
| | - Basavaraj Mathapati
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Manoj Kadam
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Abhimanyu Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | | | | | - Saritha Sivadas
- Department of Microbiology, Government Medical College, Kozhikode, India
| | - N. P. Akash
- Department of Microbiology, Government Medical College, Kozhikode, India
| | - T. V. Vimisha
- Department of Microbiology, Government Medical College, Kozhikode, India
| | - K. V. Keerthi
- Department of Microbiology, Government Medical College, Kozhikode, India
| |
Collapse
|
28
|
Sahay RR, Patil DY, Sapkal GN, Deshpande GR, Shete AM, Nyayanit DA, Kumar S, Yadav PD. SARS-CoV-2 Delta and delta derivatives impact on neutralization of Covishield recipient sera. J Infect 2022; 84:e36-e38. [PMID: 35192896 PMCID: PMC8857767 DOI: 10.1016/j.jinf.2022.02.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2022] [Accepted: 02/14/2022] [Indexed: 11/18/2022]
|
29
|
Yadav PD, Niyas VKM, Arjun R, Sahay RR, Shete AM, Sapkal GN, Pawar S, Patil DY, Gupta N, Abraham P. Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during second wave of COVID-19 pandemic. J Med Virol 2022; 94:2346-2349. [PMID: 35102566 PMCID: PMC9015449 DOI: 10.1002/jmv.27638] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 01/07/2022] [Accepted: 01/27/2022] [Indexed: 11/09/2022]
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | | | - Rajalakshmi Arjun
- Kerala Institute of Medical Sciences and Health (KIMSHEALTH), Thiruvananthapuram, Kerala, India, Pin-695029
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Shailesh Pawar
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| | - Nivedita Gupta
- ndian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India, Pin-110029
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India, Pin-411021
| |
Collapse
|
30
|
Yadav PD, Sapkal GN, Abraham P, Ella R, Deshpande G, Patil DY, Nyayanit DA, Gupta N, Sahay RR, Shete AM, Panda S, Bhargava B, Mohan VK. Neutralization of Variant Under Investigation B.1.617.1 With Sera of BBV152 Vaccinees. Clin Infect Dis 2022; 74:366-368. [PMID: 33961693 DOI: 10.1093/cid/ciab411] [Citation(s) in RCA: 134] [Impact Index Per Article: 67.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/04/2023] Open
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Raches Ella
- Bharat Biotech International Limited, Genome Valley, Hyderabad, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - V Krishna Mohan
- Bharat Biotech International Limited, Genome Valley, Hyderabad, India
| |
Collapse
|
31
|
Yadav PD, Sahay RR, Sapkal G, Nyayanit D, Shete AM, Deshpande G, Patil DY, Gupta N, Kumar S, Abraham P, Panda S, Bhargava B. Comparable neutralization of SARS-CoV-2 Delta AY.1 and Delta with individuals sera vaccinated with BBV152. J Travel Med 2021; 28:6374819. [PMID: 34581415 PMCID: PMC8500129 DOI: 10.1093/jtm/taab154] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/04/2021] [Revised: 09/14/2021] [Accepted: 09/15/2021] [Indexed: 11/12/2022]
Abstract
Sera of COVID-19 naive vaccinees, COVID-19 recovered cases with vaccination and breakthrough cases demonstrated 1.3, 2.5 and 1.9-fold reduction in neutralization titers against Delta and 1.5, 3.5, 2.8-fold against Delta AY.1 compared to B.1 respectively. However, high neutralization titers would still effectively protect against Delta, Delta AY.1 and B.1.617.3 variants.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Dimpal Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College, Pune, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, India
| |
Collapse
|
32
|
Munivenkatappa A, Sahay RR, Deshpande GR, Patil DY, Shete AM, Sapkal GN, Kumar R, Narayana M, Yadav PD, Shettar V. A case with SARS-CoV-2 reinfection from India. Indian J Med Microbiol 2021; 40:166-168. [PMID: 34789389 PMCID: PMC8590946 DOI: 10.1016/j.ijmmb.2021.09.010] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 09/22/2021] [Accepted: 09/24/2021] [Indexed: 12/29/2022]
Abstract
A healthcare worker presented with fever, cough, headache and tested positive by SARS-CoV-2 real time reverse transcriptase polymerase chain reaction (qRT-PCR). He got admitted to hospital and recovered after 14 days. After 2 months, as a screening protocol considering the high risk setup he got tested and again found to be positive for SARS-CoV-2 by qRT-PCR. Our patient had detectable levels of Anti-SARS-CoV-2 IgG antibodies during the reinfection but found negative for Neutralizing antibodies (NAb). Our findings suggest that the person after the initial infection might not develop the desired protective immunity to prevent the reinfection as demonstrated by absence of NAb.
Collapse
Affiliation(s)
- Ashok Munivenkatappa
- Indian Council of Medical Research-National Institute of Virology, Bangalore Unit, Karnataka, 560029, India.
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Gururaj R Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Ravish Kumar
- Employees' State Insurance Corporation Medical College and Hospital, Gulbarga, Karnataka, 585106, India.
| | - Marappa Narayana
- Employees' State Insurance Corporation Medical College and Hospital, Gulbarga, Karnataka, 585106, India.
| | - Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Vijay Shettar
- Employees' State Insurance Corporation Medical College and Hospital, Gulbarga, Karnataka, 585106, India.
| |
Collapse
|
33
|
Sapkal GN, Yadav PD, Sahay RR, Deshpande G, Gupta N, Nyayanit DA, Patil DY, Shete AM, Kumar S, Abraham P, Panda S, Bhargava B. Neutralization of Delta variant with sera of Covishield™ vaccinees and COVID-19-recovered vaccinated individuals. J Travel Med 2021; 28:6338089. [PMID: 34343316 PMCID: PMC8385819 DOI: 10.1093/jtm/taab119] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2021] [Revised: 07/26/2021] [Accepted: 07/27/2021] [Indexed: 02/04/2023]
Affiliation(s)
- Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Pragya D Yadav
- To whom correspondence should be addressed. Tel.: +912026006111; Fax No. +912026122669; Equal first author
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box No. 4911, Ansari Nagar, New Delhi 110029, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College, Pune, Maharashtra 411040, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411021, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box No. 4911, Ansari Nagar, New Delhi 110029, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, PO Box No. 4911, Ansari Nagar, New Delhi 110029, India
| |
Collapse
|
34
|
Sapkal G, Yadav PD, Ella R, Abraham P, Patil DY, Gupta N, Panda S, Mohan VK, Bhargava B. Neutralization of VUI B.1.1.28 P2 variant with sera of COVID-19 recovered cases and recipients of Covaxin an inactivated COVID-19 vaccine. J Travel Med 2021; 28:6277044. [PMID: 34002240 PMCID: PMC8194512 DOI: 10.1093/jtm/taab077] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/30/2021] [Revised: 05/11/2021] [Accepted: 05/11/2021] [Indexed: 01/13/2023]
Abstract
Our study has shown 1.09 and 1.92 fold reductions in the neutralizing titer with sera of individuals with natural infection and Covaxin vaccine recipients against B.1.1.28.2 variant.
Collapse
Affiliation(s)
- Gajanan Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Pragya D Yadav
- To whom correspondence should be addressed. Dr. Pragya D. Yadav, Scientist ‘E’ and Group Leader, Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Sus Road, Pashan, Pune, Maharashtra, India Pin-411021. Phone: +9120-26006111, Fax No. 91-20-26122669,
| | - Raches Ella
- Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India Pin-500 078
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India, Pin-411021
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India Pin-110029
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India Pin-110029
| | - V Krishna Mohan
- Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India Pin-500 078
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, India Pin-110029
| |
Collapse
|
35
|
Yadav PD, Sapkal GN, Ella R, Sahay RR, Nyayanit DA, Patil DY, Deshpande G, Shete AM, Gupta N, Mohan VK, Abraham P, Panda S, Bhargava B. Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin. J Travel Med 2021; 28:6316247. [PMID: 34230972 PMCID: PMC8344909 DOI: 10.1093/jtm/taab104] [Citation(s) in RCA: 65] [Impact Index Per Article: 21.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/16/2021] [Revised: 06/29/2021] [Accepted: 06/29/2021] [Indexed: 11/25/2022]
Abstract
SARS-CoV-2 variant of concern mainly Delta and Beta is global public health concern due to its impact on existing vaccines. Here, we assessed the neutralization of sera from COVID-19 recovered cases and BBV152 vaccinees against Beta and Delta variants. BBV152 vaccine found to confer significant protection against both the variants.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Raches Ella
- Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| | - V Krishna Mohan
- Bharat Biotech International Limited, Genome Valley, Hyderabad, Telangana, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| |
Collapse
|
36
|
Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B. Authors' response. Indian J Med Res 2021; 153:703-704. [PMID: 34643572 PMCID: PMC8555597 DOI: 10.4103/0971-5916.318735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
Affiliation(s)
- Labanya Mukhopadhyay
- Virology Unit, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | - Pragya D Yadav
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune 411 001, Maharashtra, India
| | - Nivedita Gupta
- Virology Unit, Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | - Sreelekshmy Mohandas
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune 411 001, Maharashtra, India
| | - Deepak Y Patil
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune 411 001, Maharashtra, India
| | - Anita Shete-Aich
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune 411 001, Maharashtra, India
| | - Samiran Panda
- Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | | |
Collapse
|
37
|
Mourya DT, Yadav PD, Patil DY, Sahay RR, Rahi M. Experiences of Indian Council of Medical Research with tick-borne zoonotic infections: Kyasanur Forest disease & Crimean-Congo haemorrhagic fever in India with One Health focus. Indian J Med Res 2021; 153:339-347. [PMID: 33906997 PMCID: PMC8204825 DOI: 10.4103/ijmr.ijmr_532_21] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Emergence and re-emergence of several pathogens have been witnessed by this century in the form of outbreaks, epidemics and pandemics. In India, the influencing factor that promotes dissemination of emerging and re-emerging viral infections is the biogeographical zones: a megadiverse country, characterized by varied geographical, climatic conditions and ever-changing socio-economical and geopolitical issues. These influence the movement of humans and animals and add layers of complexity for the identification and timely management of infectious diseases. This review focuses on two tick-borne infections: Crimean-Congo haemorrhagic fever (CCHF) and Kyasanur forest disease (KFD). In the last two decades, these viruses have emerged and caused outbreaks in different parts of India. KFD virus was initially identified in 1957 and was known to be endemic in Karnataka State while CCHF virus was first identified during 2010 in Gujarat State, India. These viruses have managed to emerge in new areas within the last decade. With changing epidemiology of these arboviruses, there is a probability of the emergence of these viruses from new areas in future. The investigations on these two diseases under the One Health focus involved early detection, quickly developing diagnostic tools, identifying stakeholders, capacity building by developing collaboration with major stakeholders to understand the epidemiology and geographical spread in domestic animal reservoirs and tick vectors in the affected areas, developing laboratory network, providing diagnostic reagents and biosafety and laboratory diagnosis training to the network laboratories to control these diseases.
Collapse
Affiliation(s)
| | - Pragya D Yadav
- Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India
| | - Rima R Sahay
- Maximum Containment Facility, ICMR-National Institute of Virology, Pune, Maharashtra, India
| | - Manju Rahi
- Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| |
Collapse
|
38
|
Yadav PD, Sapkal GN, Abraham P, Deshpande G, Nyayanit DA, Patil DY, Gupta N, Sahay RR, Shete AM, Kumar S, Panda S, Bhargava B. Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1. Clin Infect Dis 2021; 74:558-559. [PMID: 34036309 DOI: 10.1093/cid/ciab483] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gajanan N Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College (AFMC), Pune, Maharashtra, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, Ansari Nagar, New Delhi, India
| |
Collapse
|
39
|
Yadav PD, Gupta N, Nyayanit DA, Sahay RR, Shete AM, Majumdar T, Patil S, Kaur H, Nikam C, Pethani J, Patil DY, Aggarwal N, Vijay N, Narayan J. Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travelers from South Africa and Tanzania to India. Travel Med Infect Dis 2021; 41:102023. [PMID: 33727176 DOI: 10.1016/j.tmaid] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2021] [Revised: 03/08/2021] [Accepted: 03/09/2021] [Indexed: 05/24/2023]
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India.
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Dimpal A Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Rima R Sahay
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Harmanmeet Kaur
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Chaitali Nikam
- Thyrocare Technologies Pvt Ltd, Navi Mumbai, Maharashtra, 400703, India
| | - Jayshri Pethani
- Smt.Nathiba Hargovandas Lakhmichand, Municipal Medical College (NHLMMC), Ahmedabad, Gujarat, 380006, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, 411021, India
| | - Neeraj Aggarwal
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Neetu Vijay
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| | - Jitendra Narayan
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi, 110029, India
| |
Collapse
|
40
|
Mukhopadhyay L, Yadav PD, Gupta N, Mohandas S, Patil DY, Shete-Aich A, Panda S, Bhargava B. Comparison of the immunogenicity & protective efficacy of various SARS-CoV-2 vaccine candidates in non-human primates. Indian J Med Res 2021; 153:93-114. [PMID: 33361645 PMCID: PMC8184077 DOI: 10.4103/ijmr.ijmr_4431_20] [Citation(s) in RCA: 24] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2020] [Indexed: 12/11/2022] Open
Abstract
BACKGROUND & OBJECTIVES The COVID-19 pandemic has emerged as a global public health crisis and research groups worldwide are engaged in developing vaccine candidates to curb its transmission, with a few vaccines having progressed to advanced stages of clinical trials. The aim of this systematic review was to compare immunogenicity and protective efficacy of various SARS-CoV-2 vaccine candidates tested in non-human primate (NHP) models. METHODS Literature on effect of SARS-CoV-2 vaccines in NHP models reported on PubMed and preprint platforms (medRxiv and bioRxiv) till October 22, 2020, was searched with the following terms: coronavirus vaccine, COVID-19 vaccine, SARS-CoV-2 vaccine, nonhuman primate, and rhesus macaque. RESULTS Our search yielded 19 studies, which reported immune response elicited by 18 vaccine candidates in NHP. All the vaccines induced detectable neutralizing antibody (NAb) titres in the serum of vaccinated animals, with some showing effective viral clearance from various organs. The vaccinated animals also showed nil to mild histopathological changes in their lungs compared to placebo groups in the trials that performed necropsy. INTERPRETATION & CONCLUSIONS Our findings highlighted onset of quick immunogenicity and protective efficacy of mRNA-1273, followed by Ad26.CoV2.S, NVX-CoV2373, BNT162b2, RBD and BBV152 vaccine candidates in preclinical trials as compared to the others. NHP data also showed correlation with clinical trial data available for a few vaccines. Preclinical trials of COVID-19 vaccine candidates in NHPs yielded promising results, with some candidates faring better than others.
Collapse
Affiliation(s)
| | - Pragya D. Yadav
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Nivedita Gupta
- Virology Unit, Indian Council of Medical Research, New Delhi, India
| | - Sreelekshmy Mohandas
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y. Patil
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Anita Shete-Aich
- Maximum Containment Laboratory, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra, India
| | - Samiran Panda
- Division of Epidemiology & Communicable Diseases, Indian Council of Medical Research, New Delhi, India
| | | |
Collapse
|
41
|
Yadav PD, Ella R, Kumar S, Patil DR, Mohandas S, Shete AM, Vadrevu KM, Bhati G, Sapkal G, Kaushal H, Patil S, Jain R, Deshpande G, Gupta N, Agarwal K, Gokhale M, Mathapati B, Metkari S, Mote C, Nyayanit D, Patil DY, Sai Prasad BS, Suryawanshi A, Kadam M, Kumar A, Daigude S, Gopale S, Majumdar T, Mali D, Sarkale P, Baradkar S, Gawande P, Joshi Y, Fulari S, Dighe H, Sharma S, Gunjikar R, Kumar A, Kalele K, Srinivas VK, Gangakhedkar RR, Ella KM, Abraham P, Panda S, Bhargava B. Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques. Nat Commun 2021; 12:1386. [PMID: 33654090 PMCID: PMC7925524 DOI: 10.1038/s41467-021-21639-w] [Citation(s) in RCA: 59] [Impact Index Per Article: 19.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/28/2020] [Accepted: 02/04/2021] [Indexed: 01/08/2023] Open
Abstract
The COVID-19 pandemic is a global health crisis that poses a great challenge to the public health system of affected countries. Safe and effective vaccines are needed to overcome this crisis. Here, we develop and assess the protective efficacy and immunogenicity of an inactivated SARS-CoV-2 vaccine in rhesus macaques. Twenty macaques were divided into four groups of five animals each. One group was administered a placebo, while three groups were immunized with three different vaccine candidates of BBV152 at 0 and 14 days. All the macaques were challenged with SARS-CoV-2 fourteen days after the second dose. The protective response was observed with increasing SARS-CoV-2 specific IgG and neutralizing antibody titers from 3rd-week post-immunization. Viral clearance was observed from bronchoalveolar lavage fluid, nasal swab, throat swab and lung tissues at 7 days post-infection in the vaccinated groups. No evidence of pneumonia was observed by histopathological examination in vaccinated groups, unlike the placebo group which exhibited interstitial pneumonia and localization of viral antigen in the alveolar epithelium and macrophages by immunohistochemistry. This vaccine candidate BBV152 has completed Phase I/II (NCT04471519) clinical trials in India and is presently in phase III, data of this study substantiates the immunogenicity and protective efficacy of the vaccine candidates.
Collapse
Affiliation(s)
- Pragya D Yadav
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Raches Ella
- Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, Telangana, India
| | - Sanjay Kumar
- Department of Neurosurgery, Command Hospital (Southern Command), Armed Forces Medical College (AFMC), Pune, 411040, Maharashtra, India
| | - Dilip R Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Sreelekshmy Mohandas
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Anita M Shete
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Krishna M Vadrevu
- Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, Telangana, India
| | - Gaurav Bhati
- Army Institute of Cardio-Thoracic Sciences, Pune, 411040, Maharashtra, India
| | - Gajanan Sapkal
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Himanshu Kaushal
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Savita Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Rajlaxmi Jain
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Gururaj Deshpande
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Nivedita Gupta
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India
| | - Kshitij Agarwal
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India
| | - Mangesh Gokhale
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Basavaraj Mathapati
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Siddhanath Metkari
- ICMR-National Institute for Research in Reproductive Health, Mumbai, 400012, Maharashtra, India
| | - Chandrashekhar Mote
- Department of Veterinary Pathology, Krantisinh Nana Patil College of Veterinary Science, Shirwal, 412801, Maharashtra, India
| | - Dimpal Nyayanit
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Deepak Y Patil
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - B S Sai Prasad
- Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, Telangana, India
| | - Annasaheb Suryawanshi
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Manoj Kadam
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Abhimanyu Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Sachin Daigude
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Sanjay Gopale
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Triparna Majumdar
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Deepak Mali
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Prasad Sarkale
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Shreekant Baradkar
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Pranita Gawande
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Yash Joshi
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Sidharam Fulari
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Hitesh Dighe
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Sharda Sharma
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Rashmi Gunjikar
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Abhinendra Kumar
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Kaumudi Kalele
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Vellimedu K Srinivas
- Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, Telangana, India
| | - Raman R Gangakhedkar
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India
| | - Krishna M Ella
- Bharat Biotech International Limited, Genome Valley, Hyderabad, 500 078, Telangana, India
| | - Priya Abraham
- Indian Council of Medical Research-National Institute of Virology, Pune, 411021, Maharashtra, India
| | - Samiran Panda
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India
| | - Balram Bhargava
- Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India.
| |
Collapse
|
42
|
Yadav PD, Nyayanit DA, Sahay RR, Sarkale P, Pethani J, Patil S, Baradkar S, Potdar V, Patil DY. Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage. J Travel Med 2021; 28:6121695. [PMID: 33506252 PMCID: PMC7928800 DOI: 10.1093/jtm/taab009] [Citation(s) in RCA: 37] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2021] [Revised: 01/11/2021] [Accepted: 01/12/2021] [Indexed: 11/18/2022]
Abstract
We have isolated the new severe acute respiratory syndrome coronavirus-2 variant of concern 202 012/01 from the positive coronavirus disease 2019 cases that travelled from the UK to India in the month of December 2020. This emphasizes the need for the strengthened surveillance system to limit the local transmission of this new variant.
Collapse
Affiliation(s)
- Pragya D Yadav
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Dimpal A Nyayanit
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Rima R Sahay
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Prasad Sarkale
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Jayshri Pethani
- Department of Microbiology, Smt. Nathiba Hargovandas Lakhmichand, Municipal Medical College (NHLMMC), Ahmedabad, Gujarat, 380006, India
| | - Savita Patil
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Shreekant Baradkar
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| | - Varsha Potdar
- Influenza Department, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 001, India
| | - Deepak Y Patil
- Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, Maharashtra 411 021, India
| |
Collapse
|
43
|
Jain R, Sarkale P, Mali D, Shete AM, Patil DY, Majumdar T, Suryawanshi A, Patil S, Mohandas S, Yadav PD. Inactivation of SARS-CoV-2 by gamma irradiation. Indian J Med Res 2020; 153:196-198. [PMID: 33818476 PMCID: PMC8184089 DOI: 10.4103/ijmr.ijmr_2789_20] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Rajlaxmi Jain
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Prasad Sarkale
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Deepak Mali
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Anita M Shete
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Deepak Y Patil
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Triparna Majumdar
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Annasaheb Suryawanshi
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Savita Patil
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Sreelekshmy Mohandas
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| | - Pragya D Yadav
- Maximum Containment Laboratory, ICMR-National Institute of Virology, Pune 411 021, Maharashtra, India
| |
Collapse
|
44
|
Gupta N, Yadav PD, Patil DY, Sapkal G. Preparedness of public health-care system for Zika virus outbreak: An Indian perspective. J Infect Public Health 2020; 13:949-955. [PMID: 32340832 DOI: 10.1016/j.jiph.2020.03.016] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Revised: 03/18/2020] [Accepted: 03/26/2020] [Indexed: 11/20/2022] Open
Abstract
Zika virus is a mosquito-borne flavivirus that has emerged recently and affected in many countries. Since its discovery in Uganda in 1947, two major outbreaks were reported from Yap Islands in 2007 and French Polynesia in 2013. In 2015, the first case of ZIKV infection was confirmed from Brazil followed by a report of cases from American and Caribbean countries. In February 2016, the World Health Organization declared ZIKV infection a Public Health Emergency of International Concern. India reported the first Zika case in 2017. Subsequently, 157 laboratory-confirmed cases of ZIKV including 63 pregnant women were reported from Rajasthan, India in 2018. Since 2014, many countries took initiatives to boost their public health system to combat ZIKV. However, there is still scope for the improvement. This review describes ZIKV outbreaks, diagnostic challenges, surveillance and control measures in India and the future perspective to deal with the ZIKV outbreak in India.
Collapse
Affiliation(s)
- Nivedita Gupta
- Epidemiology and Communicable Diseases, Indian Council of Medical Research, V. Ramalingaswami Bhawan, P.O. Box No. 4911, Ansari Nagar, New Delhi 110029, India.
| | - Pragya D Yadav
- ICMR-National Institute of Virology, Sus-Pashan Road, Pune, Maharashtra 411021, India
| | - Deepak Y Patil
- ICMR-National Institute of Virology, Sus-Pashan Road, Pune, Maharashtra 411021, India
| | - Gajanan Sapkal
- ICMR-National Institute of Virology, Sus-Pashan Road, Pune, Maharashtra 411021, India
| |
Collapse
|
45
|
Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT. Corrigendum: Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India. J Gen Virol 2019; 100:1340. [PMID: 31481150 DOI: 10.1099/jgv.0.001127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Affiliation(s)
- Pragya D Yadav
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Dimpal A Nyayanit
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Cesar G Albarino
- Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Shilpi Jain
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Lisa W Guerrero
- Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Sandeep Kumar
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Stuart T Nichol
- Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Devendra T Mourya
- Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
46
|
Khadke NB, Patil AA, Patil DY, Borhade AV. Isophthaloyl-Based Selective Fluorescence Receptor for Zn (II) Ion in Semi-Aqueous Medium. J Fluoresc 2019; 29:837-843. [PMID: 31309389 DOI: 10.1007/s10895-019-02385-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2018] [Accepted: 05/06/2019] [Indexed: 12/23/2022]
Abstract
A novel Isophthaloyl-based symmetrical (12E,21E)-N1',N3'-bis(2-hydroxybenzylidene) isophthalohydrazide, receptor (1) was synthesized and characterized using various spectroscopic technique. The reorganization ability of receptor (1) was evaluated in semi-aqueous medium and shows significant enhancement in fluorescence intensity for Zn (II) ion over various metal ions in CH3CN:H2O (1:1, v/v). The 1:2 binding stoichiometry between receptor (1) and Zn (II) ion was established using Job's plot and the proposed complex structure was calculated by applying Density Functional Theory (DFT) method. The binding constant (Ka) of receptor (1) with Zn (II) ion was established with the Benesi-Hildebrand plot, Scatchard and Connor's plot and the values are 1.00 × 104 M-1, 1.05× 104 M-1 and 1.05× 104 M-1 respectively. The limit of detection (LOD) and limit of quantification (LOQ) of receptor (1) and Zn (II) ion was 0.292 μM and 0.974 μM respectively. The binding mode was due to photo-induced electron transfer (PET) and the coordination of Zn (II) ion with C = N hydroxyl group of receptor (1). Electrochemical analysis of metal free receptor (1) and with Zn (II) ion also confirmed the formation of complex.
Collapse
Affiliation(s)
- N B Khadke
- Science Department, Government Residential Women's Polytechnic College, Latur, 413512, India
| | - A A Patil
- Department of Applied Science and Mathematics, K. K. W Institute of Engineering Education and Research, Nashik,, 422003, India
| | - D Y Patil
- Department of Applied Science and Mathematics, K. K. W Institute of Engineering Education and Research, Nashik,, 422003, India
| | - A V Borhade
- Department of Applied Science and Mathematics, K. K. W Institute of Engineering Education and Research, Nashik,, 422003, India.
| |
Collapse
|
47
|
Yadav PD, Pardeshi PG, Patil DY, Shete AM, Mourya DT. Persistence of IgG antibodies in survivors of Crimean Congo hemorrhagic fever virus infection, India. J Infect Public Health 2019; 12:598-599. [DOI: 10.1016/j.jiph.2019.04.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2019] [Revised: 04/02/2019] [Accepted: 04/04/2019] [Indexed: 10/27/2022] Open
|
48
|
Mourya DT, Yadav PD, Gurav YK, Pardeshi PG, Shete AM, Jain R, Raval DD, Upadhyay KJ, Patil DY. Crimean Congo hemorrhagic fever serosurvey in humans for identifying high-risk populations and high-risk areas in the endemic state of Gujarat, India. BMC Infect Dis 2019; 19:104. [PMID: 30709372 PMCID: PMC6359815 DOI: 10.1186/s12879-019-3740-x] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/28/2018] [Accepted: 01/25/2019] [Indexed: 11/10/2022] Open
Abstract
Background Crimean Congo Hemorrhagic Fever (CCHF) is a highly infectious zoonotic disease of humans transmitted by Hyalomma ticks. Earlier studies have shown CCHF seroprevalence in livestock throughout India, yet sporadic outbreaks have been recorded mostly from the Gujarat state of India since 2011. Occupational vulnerability to CCHF for animal handlers, veterinarians, abattoir workers, and healthcare workers has been documented. The current study was planned to determine the seroprevalence of CCHF with an intention to identify the high -risk population and high -risk areas from Gujarat state, India. Methods Based on the socio-clinical data, the human population of Gujarat was divided into eight categories viz. A: CCHF affected person/house/close contact, B: Neighborhood contacts, C: Animal handlers, D: General population, E: Farmers, F: Abattoir workers, G: Veterinarian, H: Healthcare workers. A total of 4978 human serum samples were collected from 33 districts of Gujarat during year 2015, 2016 and 2017. All the samples were screened for the presence of anti-CCHFV IgG using indigenously developed anti-CCHFV IgG ELISA. Univariate regression analysis was performed to recognize significant risk factors for CCHF seropositivity. Results Twenty-five serum samples were found to be positive with an overall CCHF human seropositivity of 0.5% (95% CI 0.30–0.74%). Gender predisposition to CCHF prevalence was observed in males (OR: 2.80; p-value: 0.020). The risk for seropositivity increased sevenfold when a person was in contact or neighbor with a CCHF case (OR 7.02; p-value: < 0.0001). No significant difference in seropositivity was observed within different age groups. Veterinarians, healthcare workers, and control group were found to be seronegative for CCHF. Conclusions In-spite of CCHF sporadic outbreaks reported in Gujarat, the seropositivity for CCHF in the state was low as compared to other endemic countries. Males, close contacts and neighbors were identified as a high-risk population for CCHF infection. To recognize the high-risk area, tick screening and animal serosurvey would be a wiser choice. The study also suggests circulation and under diagnoses of CCHFV in the naïve regions of Gujarat.
Collapse
Affiliation(s)
- Devendra T Mourya
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India.
| | - Pragya D Yadav
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| | - Yogesh K Gurav
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| | - Prachi G Pardeshi
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| | - Anita M Shete
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| | - Rajlaxmi Jain
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| | - Dinkar D Raval
- State Health Society, Health and Family Welfare Department, Gandhinagar, Gujarat, India
| | | | - Deepak Y Patil
- ICMR-National Institute of Virology, 20-A, Dr. Ambedkar Road, Pune, Maharashtra, Pin 411001, India
| |
Collapse
|
49
|
Yadav PD, Shete AM, Nyayanit DA, Albarino CG, Jain S, Guerrero LW, Kumar S, Patil DY, Nichol ST, Mourya DT. Identification and characterization of novel mosquito-borne (Kammavanpettai virus) and tick-borne (Wad Medani) reoviruses isolated in India. J Gen Virol 2018; 99:991-1000. [PMID: 29939123 DOI: 10.1099/jgv.0.001102] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
In 1954, a virus named Wad Medani virus (WMV) was isolated from Hyalomma marginatum ticks from Maharashtra State, India. In 1963, another virus was isolated from Sturnia pagodarum birds in Tamil Nadu, India, and named Kammavanpettai virus (KVPTV) based on the site of its isolation. Originally these virus isolates could not be identified with conventional methods. Here we describe next-generation sequencing studies leading to the determination of their complete genome sequences, and identification of both virus isolates as orbiviruses (family Reoviridae). Sequencing data showed that KVPTV has an AT-rich genome, whereas the genome of WMV is GC-rich. The size of the KVPTV genome is 18 234 nucleotides encoding proteins ranging 238-1290 amino acids (aa) in length. Similarly, the size of the WMV genome is 16 941 nucleotides encoding proteins ranging 214-1305 amino acids in length. Phylogenetic analysis of the VP1 gene, along with the capsid genes VP5 and VP7, revealed that KVPTV is likely a novel mosquito-borne virus and WMV is a tick-borne orbivirus. This study focuses on the phylogenetic comparison of these newly identified orbiviruses with mosquito-, tick- and Culicoides-borne orbiviruses isolated in India and other countries.
Collapse
Affiliation(s)
- Pragya D Yadav
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Anita M Shete
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Dimpal A Nyayanit
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Cesar G Albarino
- 2Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Shilpi Jain
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Lisa W Guerrero
- 2Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Sandeep Kumar
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Deepak Y Patil
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| | - Stuart T Nichol
- 2Viral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
| | - Devendra T Mourya
- 1Maximum Containment Laboratory, National Institute of Virology, Pune, Maharashtra, India
| |
Collapse
|
50
|
Abstract
In January 2016, a migrant worker who returned home to India after becoming ill in Oman was confirmed to have Crimean-Congo hemorrhagic fever (CCHF). Physicians should include CCHF in the differential diagnosis for patients with hemorrhagic signs and a history of recent travel to any area where CCHF is endemic or prevalent.
Collapse
|